-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Docetaxel in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Docetaxel in Cervical Cancer Drug Details: docetaxel (ATI-1123) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Docetaxel in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Docetaxel in Non-Small Cell Lung Cancer Drug Details: docetaxel (ATI-1123)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Docetaxel in Prostate Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Docetaxel in Prostate Cancer Drug Details: docetaxel (ATI-1123) is under development for the treatment of...
-
Product Insights
Hip Reconstruction – BioPro, Inc. – PSL
GlobalData, the industry analysis specialist, has released its latest report: Hip Reconstruction - BioPro, Inc. - PSL. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the discounting...